Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection

Overview of attention for article published in Biologics: Targets & Therapy, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#37 of 287)
High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 102 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

AI Drugs So Far

Science Magazine, 13 May 2024

Here's a new paper whose title asks a question that's on a lot of peoples' minds these days: "How successful are AI-discovered…